4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-019979
Chief Executive Officer sold 7,800 shares at an average $39.48 ($307,953)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-14 | Sale | −700 | $39.10 | $27,370 | 334,837 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-14 | Sale | −3,200 | $40.48 | $129,536 | 331,637 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-03-15 | Sale | −3,900 | $38.73 | $151,047 | 327,737 | I |
| Open-market sales · 7,800 sh · avg $39.48 · $307,953 | |||||||
Loading xslF345X03/doc4.xml…